{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:53:31Z","timestamp":1771602811599,"version":"3.50.1"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vph.2023.107144","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T12:50:18Z","timestamp":1675428618000},"page":"107144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Long-acting opioids and cardiovascular diseases: Help or hindrance!"],"prefix":"10.1016","volume":"149","author":[{"given":"Ankita","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhoomika M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2023.107144_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102616","article-title":"Opioid-related deaths in Europe: strategies for a comprehensive approach to address a major public health concern","volume":"76","author":"Alho","year":"2020","journal-title":"Int J Drug Policy."},{"key":"10.1016\/j.vph.2023.107144_bb0010","first-page":"577","article-title":"A systematic review of the cardiotoxicity of methadone","volume":"14","author":"Alinejad","year":"2015","journal-title":"EXCLI J."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1360-0443.2009.02549.x","article-title":"Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: mortality assessment study","volume":"104","author":"Anchersen","year":"2009","journal-title":"Addiction."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-3806(85)90070-7","article-title":"Ontogenesis of proenkephalin products in rat striatum and the inhibitory effects of low-level lead exposure","volume":"354","author":"Bailey","year":"1985","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-2828(92)91160-7","article-title":"Screening for opioids in dog heart","volume":"24","author":"Barron","year":"1992","journal-title":"J Mol Cell Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000492616","article-title":"Opioids and cardiac arrhythmia: a literature review","volume":"27","author":"Behzadi","year":"2018","journal-title":"Med Princ Pract."},{"key":"10.1016\/j.vph.2023.107144_bb0035","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1039\/b111551k","article-title":"Morphine, the Proteus of organic molecules","volume":"11","author":"Blakemore","year":"2002","journal-title":"Chem Commun (Camb)."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/jcbfm.1985.57","article-title":"Ischemic brain damage in rats following cardiac arrest using va long-term recovery model","volume":"5","author":"Blomqvist","year":"1985","journal-title":"J Cereb Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1476-5381.1989.tb12019.x","article-title":"The antiarrhythmic and cardiac electrophysiological effects of buprenorphine","volume":"97","author":"Boachie-Ansah","year":"1989","journal-title":"Br J Pharmacol."},{"issue":"12","key":"10.1016\/j.vph.2023.107144_bb0050","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","article-title":"A brief history of opiates, opioid peptides, and opioid receptors","volume":"90","author":"Brownstein","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2\u20133","key":"10.1016\/j.vph.2023.107144_bb0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0014-5793(94)00561-3","article-title":"Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type","volume":"347","author":"Bunzow","year":"1994","journal-title":"FEBS Lett."},{"issue":"1(8226)","key":"10.1016\/j.vph.2023.107144_bb0060","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(81)91636-6","article-title":"Naloxone in shock","volume":"25","author":"Burnie","year":"1981","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000138713","article-title":"Actions of the opioid antagonist, nalmefene, and congeners on reperfusion cardiac arrhythmias and regional left coronary blood flow","volume":"41","author":"Caldwell","year":"1990","journal-title":"Pharmacology."},{"issue":"4531","key":"10.1016\/j.vph.2023.107144_bb0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2023.107144_bb0075","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/pme.12915","article-title":"Cardiac Effects of Opioid Therapy","volume":"16","author":"Chen","year":"2015","journal-title":"Pain Med."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2007.10.009","article-title":"A community-based evaluation of sudden death associated with therapeutic levels of methadone","volume":"121","author":"Chugh","year":"2008","journal-title":"Am J Med."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0090","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1210\/endo-103-4-1297","article-title":"Blood-brain barrier restriction of peptides and the low uptake of enkephalins","volume":"103","author":"Cornford","year":"1978","journal-title":"Endocrinology."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0095","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1210\/endo-103-4-1297","article-title":"Blood-brain barrier restriction of peptides and the low uptake of enkephalins","volume":"103","author":"Cornford","year":"1978","journal-title":"Endocrinology."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpainsymman.2004.06.012","article-title":"Measurement of QTc in patients receiving chronic methadone therapy","volume":"29","author":"Cruciani","year":"2005","journal-title":"J Pain Symptom Manage."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0110","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00122.2006","article-title":"Repeated delta1-opioid receptor stimulation reduces delta2-opioid receptor responses in the SA node","volume":"291","author":"Deo","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1\u20132","key":"10.1016\/j.vph.2023.107144_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0304-3940(88)90280-7","article-title":"Increased content of immunoreactive Leu-enkephalin and alteration of delta-opioid receptor in hearts of spontaneously hypertensive rats","volume":"94","author":"Dumont","year":"1988","journal-title":"Neurosci Lett."},{"issue":"14","key":"10.1016\/j.vph.2023.107144_bb0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0125","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"Eap","year":"2007","journal-title":"Clin Pharmacol Ther."},{"issue":"12","key":"10.1016\/j.vph.2023.107144_bb0130","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00005344-198605000-00005","article-title":"Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors","volume":"8","author":"Ensinger","year":"1986","journal-title":"J Cardiovasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.vph.2023.107144_bb0140","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/hrt.2006.100180","article-title":"Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen","volume":"93","author":"Fanoe","year":"2007","journal-title":"Heart."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/10550887.2013.824333","article-title":"Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up","volume":"32","author":"Fareed","year":"2013","journal-title":"J Addict Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2023.107144_bb0150","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1526-4637.2009.00666.x","article-title":"Long-acting opioids and short-acting opioids: appropriate use in chronic pain management","volume":"10","author":"Fine","year":"2009","journal-title":"Pain Med."},{"issue":"16","key":"10.1016\/j.vph.2023.107144_bb0155","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jcin.2019.05.028","article-title":"Effects of methylnaltrexone on ticagrelor-induced antiplatelet effects in coronary artery disease patients treated with morphine","volume":"12","author":"Franchi","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000137717","article-title":"Perfusion of the fourth cerebral ventricle with the synthetic opioid peptide, FK 33-824, induces dose-related bradycardia and naloxone-reversible respiratory depression in the awake dog","volume":"25","author":"Freye","year":"1982","journal-title":"Pharmacology."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00511405","article-title":"On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro","volume":"332","author":"Fuder","year":"1986","journal-title":"Naunyn. Schmiedebergs Arch Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000542-198602000-00008","article-title":"Prolonged antagonism of opioid action with intravenous nalmefene in man","volume":"64","author":"Gal","year":"1986","journal-title":"Anesthesiology."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(84)90351-0","article-title":"Cardiac slowing induced by peripheral kappa-opiate receptor stimulation in rats","volume":"102","author":"Gautret","year":"1984","journal-title":"Eur J Pharmacol."},{"issue":"8","key":"10.1016\/j.vph.2023.107144_bb0180","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0002-9149(03)00906-8","article-title":"QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone","volume":"92","author":"Gil","year":"2003","journal-title":"Am J Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0196-9781(83)90109-2","article-title":"Mechanism of the cardiovascular response to systemic intravenous administration of leucine-enkephalin in the conscious dog","volume":"4","author":"Giles","year":"1983","journal-title":"Peptides."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpainsymman.2004.01.003","article-title":"A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002","volume":"28","author":"Gilson","year":"2004","journal-title":"J Pain Symptom Manage."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0306-3623(90)90691-E","article-title":"Opioid receptors and prejunctional modulation of capsaicin-sensitive sensory nerves in guinea-pig left atrium","volume":"21","author":"Giuliani","year":"1990","journal-title":"Gen Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(97)01076-5","article-title":"Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium","volume":"332","author":"Giuliani","year":"1997","journal-title":"Eur J Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00003088-199835030-00002","article-title":"Sustained relief of chronic pain","volume":"35","author":"Gourlay","year":"1998","journal-title":"Clin Pharmacokinet."},{"issue":"9741","key":"10.1016\/j.vph.2023.107144_bb0210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0215","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1213\/ANE.0b013e3181b92201","article-title":"Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion","volume":"109","author":"Gross","year":"2009","journal-title":"Anesth Analg."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/15360288.2012.757575","article-title":"Assessment of extended-release opioid analgesics for the treatment of chronic pain","volume":"27","author":"Gudin","year":"2013","journal-title":"J Pain Palliat Care Pharmacother."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(88)90328-7","article-title":"Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats","volume":"156","author":"Gulati","year":"1988","journal-title":"Eur J Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0230","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0235","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005426","article-title":"Cardioprotective effects of intracoronary morphine in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a prospective, randomized trial","volume":"6","author":"Gwag","year":"2017","journal-title":"J Am Heart Assoc."},{"issue":"5 Pt 2","key":"10.1016\/j.vph.2023.107144_bb0240","first-page":"H796","article-title":"Effect of endorphins on heart rate and blood pressure in adult dogs","volume":"250","author":"Haddad","year":"1986","journal-title":"Am J Physiol."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10840-009-9465-9","article-title":"Ventricular arrhythmias in patients treated with methadone for opioid dependence","volume":"28","author":"Hanon","year":"2010","journal-title":"J Interv Card Electrophysiol."},{"issue":"35","key":"10.1016\/j.vph.2023.107144_bb0250","doi-asserted-by":"crossref","first-page":"31036","DOI":"10.1074\/jbc.M502540200","article-title":"G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes","volume":"280","author":"Head","year":"2005","journal-title":"J Biol Chem."},{"key":"10.1016\/j.vph.2023.107144_bb0255","first-page":"417","article-title":"Autoradiography of receptor distributions in thalamus suggests an endocrine function for neurotransmitters: evidence from comparative anatomy of the opiate system","author":"Herkenham","year":"1988","journal-title":"In Cellular Thalamic Mechanisms."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0260","first-page":"303","article-title":"The antifibrillatory effect of fentanyl, sufentanil and carfentanil in the acute phase of local myocardial ischaemia in the dog","volume":"44","author":"Hess","year":"1989","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.vph.2023.107144_bb0265","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.pa.23.040183.002545","article-title":"Cardiovascular effects of endogenous opiate systems","volume":"23","author":"Holaday","year":"1983","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010152","article-title":"The movement trial","volume":"8","author":"Holm","year":"2019","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.vph.2023.107144_bb0275","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vph.2023.107144_bb0280","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.vph.2023.107144_bb0285","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vph.2023.107144_bb0290","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vph.2023.107144_bb0295","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vph.2023.107144_bb0300","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vph.2023.107144_bb0305","author":"Food and Drug Administration"},{"key":"10.1016\/j.vph.2023.107144_bb0310","author":"Society of Actuaries"},{"key":"10.1016\/j.vph.2023.107144_bb0315","author":"World Health Organization"},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0320","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2000.tb00420.x","article-title":"Identification of opioid receptors in the sympathetic and parasympathetic nerves of guinea-pig atria","volume":"14","author":"Hung","year":"2000","journal-title":"Fundam Clin Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-2999(85)90216-X","article-title":"[D-Met2,Pro5] enkephalinamide activates cardioinhibitory efferents in anaesthetized dogs","volume":"110","author":"Inoue","year":"1985","journal-title":"Eur J Pharmacol."},{"issue":"4 Suppl","key":"10.1016\/j.vph.2023.107144_bb0330","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin J Pain."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0335","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin J Pain."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0340","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/107424840100600408","article-title":"Delta opioid receptors inhibit vagal bradycardia in the sinoatrial node","volume":"6","author":"Jackson","year":"2001","journal-title":"J Cardiovasc Pharmacol Ther."},{"issue":"18","key":"10.1016\/j.vph.2023.107144_bb0345","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(94)11232-8","article-title":"The partial mu opiate agonist buprenorphine protects a sub-population of thalamic reticular neurons following cardiac arrest in rats","volume":"185","author":"Jones","year":"1995","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.vph.2023.107144_bb0355","first-page":"18","article-title":"Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances","volume":"131","author":"Joranson","year":"1993","journal-title":"NIDA Res Monogr."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0360","first-page":"343","article-title":"Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation","volume":"98","author":"Jordan","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0365","first-page":"6","article-title":"Methadone maintenance treatment (MMT)","volume":"67","author":"Joseph","year":"2000","journal-title":"Mt Sinai J Med."},{"issue":"9","key":"10.1016\/j.vph.2023.107144_bb0370","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/add.13013","article-title":"Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","volume":"110","author":"Kao","year":"2015","journal-title":"Addiction."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0375","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K (+) currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J Pharmacol Exp Ther."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0380","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/jcbfm.1992.34","article-title":"Global cerebral ischemia associated with cardiac arrest in the rat: I. Dynamics of early neuronal changes","volume":"12","author":"Kawai","year":"1992","journal-title":"J Cereb Blood Flow Metab."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0385","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-9378(98)70529-0","article-title":"Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous mu-opioid agonists","volume":"178","author":"Kett","year":"1998","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0390","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0022-3565(25)21059-X","article-title":"Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides","volume":"251","author":"Kiritsy-Roy","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0395","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0400","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0024-3205(75)90243-X","article-title":"Some thoughts on the significance of enkephalin the endogenous ligand","volume":"17","author":"Kosterlitz","year":"1975","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0405","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1592\/phco.25.4.611.61020","article-title":"Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes","volume":"25","author":"Krantz","year":"2005","journal-title":"Pharmacotherapy."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0410","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","article-title":"Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes","volume":"23","author":"Krantz","year":"2003","journal-title":"Pharmacotherapy."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0415","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med."},{"issue":"11","key":"10.1016\/j.vph.2023.107144_bb0420","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1592\/phco.2005.25.11.1523","article-title":"Effects of methadone on QT-interval dispersion","volume":"25","author":"Krantz","year":"2005","journal-title":"Pharmacotherapy."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0425","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19066","article-title":"Association of medicaid expansion with opioid overdose mortality in the United States","volume":"3","author":"Kravitz-Wirtz","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0430","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-291X(85)80134-0","article-title":"Opiate binding in rat hearts: modulation of binding after hemorrhagic shock","volume":"127","author":"Krumins","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0435","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0143-4179(87)90048-5","article-title":"Characterization of dermorphin binding to membranes of rat brain and heart","volume":"9","author":"Krumins","year":"1987","journal-title":"Neuropeptides."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0440","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/20.6.369","article-title":"Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J Anal Toxicol."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0445","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/20.6.369","article-title":"Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J Anal Toxicol."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0450","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.CIR.0000048894.99865.02","article-title":"Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0455","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1017\/S0020818300011620","article-title":"The single convention on Narcotic Drugs, 1961","volume":"16","author":"Lande","year":"1962","journal-title":"International Organization."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0460","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00002508-199709000-00009","article-title":"Pain knowledge and attitudes of healthcare providers: practice characteristic differences","volume":"13","author":"Lebovits","year":"1997","journal-title":"Clin J Pain."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0465","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(85)90013-5","article-title":"Sensitivity to dynorphin-(1-13) of the presynaptic inhibitory opiate receptors of the guinea-pig heart","volume":"117","author":"Ledda","year":"1985","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0470","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(82)90476-9","article-title":"Possible presynaptic inhibitory effect of etorphine on sympathetic nerve terminals of guinea-pig heart","volume":"85","author":"Ledda","year":"1982","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0475","first-page":"71","article-title":"Blood-brain barrier permeability for the ligands of opioid receptors","volume":"65","author":"Lishmanov","year":"2002","journal-title":"Eksp Klin Farmakol."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0480","first-page":"40","article-title":"Evaluation of the anti- arrhythmic potency of naltrexone in the isolated ischaemic rat heart","volume":"9","author":"Liu","year":"1988","journal-title":"Zhongguo Yao Li XueBao."},{"issue":"9","key":"10.1016\/j.vph.2023.107144_bb0485","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/mend-4-9-1408","article-title":"Association of proenkephalin transcripts with polyribosomes in the heart","volume":"4","author":"Low","year":"1990","journal-title":"Mol Endocrinol."},{"issue":"11","key":"10.1016\/j.vph.2023.107144_bb0490","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26614","article-title":"The frequency of QTc prolongation among pediatric and young adult patients receiving methadone for cancer pain","volume":"64","author":"Madden","year":"2017","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s002100100450","article-title":"Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP 4 and cannabinoid CB 1 receptors","volume":"364","author":"Malinowska","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"2 Suppl","key":"10.1016\/j.vph.2023.107144_bb0500","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.36076\/ppj.2008\/11\/S63","article-title":"Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Physician."},{"issue":"2 Suppl","key":"10.1016\/j.vph.2023.107144_bb0505","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.36076\/ppj.2008\/11\/S63","article-title":"Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Physician."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000081416","article-title":"QTc interval prolongation in patients on long-term methadone maintenance therapy","volume":"11","author":"Maremmani","year":"2005","journal-title":"Eur Addict Res."},{"issue":"10","key":"10.1016\/j.vph.2023.107144_bb0515","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","article-title":"Coronary artery disease and opioid use","volume":"93","author":"Marmor","year":"2004","journal-title":"Am J Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0520","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007629","article-title":"The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales","volume":"5","author":"Marteau","year":"2015","journal-title":"BMJ open."},{"issue":"7","key":"10.1016\/j.vph.2023.107144_bb0525","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2004.11.055","article-title":"Impact of methadone treatment on cardiac repolarization and conduction in opioid users","volume":"95","author":"Martell","year":"2005","journal-title":"Am J Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2023.107144_bb0530","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/med.21395","article-title":"Prospects for creation of cardioprotective and antiarrhythmic drugs based on opioid receptor agonists","volume":"36","author":"Maslov","year":"2016","journal-title":"Med Res Rev."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0535","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00045391-200105000-00006","article-title":"Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia","volume":"8","author":"McCarberg","year":"2001","journal-title":"Am J Ther."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0540","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/bja\/aeq089","article-title":"Assessment of nociceptin\/orphanin FQ and micro-opioid receptor mRNA in the human right atrium","volume":"104","author":"McDonald","year":"2010","journal-title":"Br J Anaesth."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0545","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-2999(92)90649-O","article-title":"Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia","volume":"210","author":"McIntosh","year":"1992","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0550","first-page":"229","article-title":"Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?","volume":"4","author":"Mujtaba","year":"2013","journal-title":"J Cardiovasc Dis Res."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0555","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00003643-199701000-00026","article-title":"Modulation of cardiac arrhythmias by opioid antagonists: a peripheral mechanism: 11","volume":"14","author":"Murphy","year":"1997","journal-title":"Eur J Anaesthesiol."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0560","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005344-199901000-00018","article-title":"Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: a peripheral mechanism","volume":"33","author":"Murphy","year":"1999","journal-title":"J Cardiovasc Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0565","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0022-3565(25)22765-3","article-title":"Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart","volume":"250","author":"Musha","year":"1989","journal-title":"J Pharmacol Exp Ther."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0570","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00005344-199806000-00021","article-title":"Baroreflex-mediated bradycardia is blunted by intravenous mu- but not kappa-opioid agonists","volume":"31","author":"Omoniyi","year":"1998","journal-title":"J Cardiovasc Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0885-3924(98)00025-6","article-title":"Barriers to cancer pain relief: fear of tolerance and addiction","volume":"16","author":"Paice","year":"1998","journal-title":"J Pain Symptom Manage."},{"issue":"11","key":"10.1016\/j.vph.2023.107144_bb0580","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0585","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cardiores.2004.04.022","article-title":"Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart","volume":"63","author":"Pepe","year":"2004","journal-title":"Cardiovasc Res."},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bb0590","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1074248418757009","article-title":"Opioids in cardiovascular disease: therapeutic options","volume":"23","author":"Rawal","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther."},{"issue":"22","key":"10.1016\/j.vph.2023.107144_bb0595","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0600","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamainternmed.2014.6294","article-title":"Out-of-hospital mortality among patients receiving methadone for noncancer pain","volume":"175","author":"Ray","year":"2015","journal-title":"JAMA Intern Med."},{"issue":"37","key":"10.1016\/j.vph.2023.107144_bb0605","first-page":"e1082","article-title":"Electrocardiographic changes in children with acute opioid poisoning: a cross-sectional study","volume":"1","author":"Riasi","year":"2019","journal-title":"Pediatr Emerg Care"},{"issue":"12","key":"10.1016\/j.vph.2023.107144_bb0610","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cvr\/23.12.1001","article-title":"Comparative effects of the opioids fentanyl and buprenorphine on ventricular vulnerability during acute coronary artery occlusion","volume":"23","author":"Saini","year":"1989","journal-title":"Cardiovasc Res."},{"issue":"5152","key":"10.1016\/j.vph.2023.107144_bb0615","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2023.107144_bb0620","first-page":"9","article-title":"Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline","volume":"85","author":"Sch\u00f6mig","year":"1990","journal-title":"Basic Res Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0625","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1076\/apab.109.1.18.4280","article-title":"Effects of ischemia on the metabolism of cardiac enkephalins","volume":"109","author":"Semmoum","year":"2001","journal-title":"Arch Physiol Biochem."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0630","first-page":"47","article-title":"Darstellung der reinen Mohnsaure (Opiumsaure) nebst einer chemischen Untersuchung des Opiums mit vorzuglicher Hinsicht auf einen darin neu entdeckten Stoff und die darin gehorigen Bemerkungen","volume":"14","author":"Serturner","year":"1805","journal-title":"Trommsdorffs Journal der Pharmazie."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0635","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12012-018-9474-y","article-title":"Electrocardiographic findings in mortalities due to pure methadone toxicity","volume":"19","author":"Sheibani","year":"2019","journal-title":"Cardiovasc Toxicol."},{"issue":"25\u201326","key":"10.1016\/j.vph.2023.107144_bb0640","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0024-3205(96)00575-9","article-title":"Lithium attenuates the effects of dynorphin A (1-13) on inositol 1,4,5-trisphosphate and intracellular Ca2+ in rat ventricular myocytes","volume":"59","author":"Sheng","year":"1996","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.vph.2023.107144_bb0645","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00380-013-0456-5","article-title":"The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue","volume":"29","author":"Sobanski","year":"2014","journal-title":"Heart Vessels."},{"issue":"1\u20132","key":"10.1016\/j.vph.2023.107144_bb0650","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2012.09.016","article-title":"Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations","volume":"129","author":"Stallvik","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0655","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00501214","article-title":"The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid \u043a-but not \u03bc-or \u03b4-receptors","volume":"329","author":"Starke","year":"1985","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"19\u201320","key":"10.1016\/j.vph.2023.107144_bb0660","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4414\/smw.2005.10939","article-title":"Methadone-induced Torsade de pointes tachycardias","volume":"135","author":"Sticherling","year":"2005","journal-title":"Swiss Med Wkly."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0665","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Physician."},{"issue":"5220","key":"10.1016\/j.vph.2023.107144_bb0670","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"HERG, a human inward rectifier in the voltage-gated potassium channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0675","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1378\/chest.64.2.203","article-title":"Morphine and autonomic control of the sinus node","volume":"64","author":"Urthaler","year":"1973","journal-title":"Chest."},{"issue":"5 Pt 2","key":"10.1016\/j.vph.2023.107144_bb0680","first-page":"H1671","article-title":"Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes","volume":"261","author":"Ventura","year":"1991","journal-title":"Am J Physiol."},{"issue":"7","key":"10.1016\/j.vph.2023.107144_bb0685","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1016\/S0021-9258(17)37698-6","article-title":"Dynorphin gene expression and release in the myocardial cell","volume":"269","author":"Ventura","year":"1994","journal-title":"J Biol Chem."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0690","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1050-1738(97)00140-0","article-title":"Opioid Peptide gene expression in the myocardial cell","volume":"8","author":"Ventura","year":"1998","journal-title":"Trends Cardiovasc Med."},{"issue":"50","key":"10.1016\/j.vph.2023.107144_bb0695","doi-asserted-by":"crossref","first-page":"30115","DOI":"10.1074\/jbc.270.50.30115","article-title":"Phorbol ester regulation of opioid peptide gene expression in myocardial cells. Role of nuclear protein kinase","volume":"270","author":"Ventura","year":"1995","journal-title":"J Biol Chem."},{"issue":"10","key":"10.1016\/j.vph.2023.107144_bb0700","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1074\/jbc.272.10.6699","article-title":"Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B","volume":"272","author":"Ventura","year":"1997","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0705","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.RES.70.1.66","article-title":"Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons","volume":"70","author":"Ventura","year":"1992","journal-title":"Circ Res."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0710","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0304-3959(02)00461-X","article-title":"High dose methadone and ventricular arrhythmias: a report of three cases","volume":"103","author":"Walker","year":"2003","journal-title":"Pain."},{"issue":"3","key":"10.1016\/j.vph.2023.107144_bb0715","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-240X(199606)19:3<205::AID-NUR4>3.0.CO;2-O","article-title":"Concerns about analgesics among patients and family caregivers in a hospice setting","volume":"19","author":"Ward","year":"1996","journal-title":"Res Nurs Health."},{"issue":"22","key":"10.1016\/j.vph.2023.107144_bb0720","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0725","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000147651","article-title":"Sympathetic noradrenergic fibers as the source of immunoreactive alpha-neoendorphin and dynorphin in the guinea pig heart","volume":"151","author":"Wegener","year":"1994","journal-title":"Acta Anat (Basel)."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0730","first-page":"H378","article-title":"Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium","volume":"275","author":"Weil","year":"1998","journal-title":"Am J Physiol."},{"issue":"2 Suppl 1","key":"10.1016\/j.vph.2023.107144_bb0735","first-page":"53","article-title":"Doctors, opioids, and the law: the effect of controlled substances regulations on cancer pain management","volume":"20","author":"Weissman","year":"1993","journal-title":"Semin Oncol."},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bb0740","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00512070","article-title":"Inhibition via opioid mu- and delta-receptors of vagal transmission in rabbit isolated heart","volume":"328","author":"Weitzell","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"5792","key":"10.1016\/j.vph.2023.107144_bb0745","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/288707a0","article-title":"Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves?","volume":"288","author":"Wilson","year":"1980","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bb0750","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13054-020-2740-y","article-title":"Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial","volume":"24","author":"Zamani","year":"2020","journal-title":"Critical Care."},{"issue":"2\u20133","key":"10.1016\/j.vph.2023.107144_bib751","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0014-5793(94)00561-3","article-title":"Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a \u03bc, \u03b4 or \u03ba opioid receptor type","volume":"347","author":"Bunzow","year":"1994","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.vph.2023.107144_bib752","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/syn.20279","article-title":"Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of \u03bc\u2010opioid receptors in prepubertal male and female mice","volume":"60","author":"Diaz","year":"2006","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.vph.2023.107144_bib753","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2009.06.021","article-title":"Complete knockout of the nociceptin\/orphanin FQ receptor in the rat does not induce compensatory changes in \u03bc, \u03b4 and \u03ba opioid receptors","volume":"163","author":"Homberg","year":"2009","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.vph.2023.107144_bib754","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cne.20378","article-title":"Comparison between \u03b4\u2010opioid receptor functional response and autoradiographic labeling in rat brain and spinal cord","volume":"481","author":"Pradhan","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.vph.2023.107144_bib755","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","article-title":"The kappa opioid receptor: from addiction to depression, and back","volume":"5","author":"Lalanne","year":"2014","journal-title":"Front. Psychiatr"},{"issue":"6549","key":"10.1016\/j.vph.2023.107144_bib756","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL 1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.vph.2023.107144_bib757","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.22-21-09210.2002","article-title":"Changes in spinal \u03b4 and \u03ba opioid systems in mice deficient in the A2A receptor gene","volume":"22","author":"Bailey","year":"2002","journal-title":"J Neurosci"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:21:53Z","timestamp":1761528113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":157,"alternative-id":["S1537189123000046"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107144","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting opioids and cardiovascular diseases: Help or hindrance!","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107144"}}